Table 3 RT compliance for each parameter
| Â | Evaluable cases | PP | (%) | DA | (%) | VU | (%) |
|---|---|---|---|---|---|---|---|
GTV | 238 | 220 | (92) | NA | Â | 18 | (8) |
ENI | 243 | 216 | (89) | 23 | (9) | 4 | (2) |
Overall treatment time | 227 | 227 | (100) | NA | Â | 0 | (0) |
Interfraction interval | 205 | 195 | (95) | 10 | (5) | 0 | (0) |
Organs at risk | Â | Â | Â | Â | Â | Â | Â |
   Spinal cord | 236 | 231 | (98) | 0 | (0) | 5 | (2) |
   Lung | 246 | 245 | (100) | 0 | (0) | 1 | (0.4) |
Heterogeneity correction | 244 | 228 | (93) | 16 | (7) | 0 | (0) |